Kenneth A. Arndt

Guest Editor for the following articles:

Dec
2007
Vol. 26. No. 4

Epidermal Nevus Syndromes

Jeffrey L. Sugarman, MD, PhD

Although many continue to use the term “epidermal nevus syndrome,” it is now understood that this is not one disease, but rather a heterogeneous group each with distinct genetic profiles but defined by a common cutaneous phenotype: the presence of epidermal and adnexal hamartomas that are associated with other organ system involvement.

MORE
Mar
2002
Vol. 21. No. 1

Erratum

Alan R. Shalita, MD

In the article, “Isotretinoin Dosing: Past, Present, and Future” (Hirsch and Shalita, Seminars in Cutaneous Medicine and Surgery 20:162-165), a dosage error appeared. The text read “In this group of patients, treatment with doses as low as 10 to 20 mg/kg/day for 6 to 8 months produces equally good results with a lower severity of side effects.” The corrected passage reads “as low as 10 to 20 mg/day.”

MORE
Dec
2002
Vol. 21. No. 4

Intense Pulsed-light Photorejuvenation

Neil S. Sadick, MD, FAAD, FAACS, FACP, FACPh | Robert A Weiss, MD, FAAD, FACPh

In an attempt to limit the prolonged postoperative healing associated with ablative laser skin resurfacing
and in response to growing public interest in less invasive treatment modalifies, nonablative laser
and light source technology was developed.

MORE
Dec
2017
Vol. 36. No. 4

Noninvasive body contouring

Nicole Y Lee, MD, MPH
In a society where stigma surrounds cosmetic procedures and yet a thin and sculpted physique is idealized, noninvasive body contouring satisfies the demand to reduce excess and undesired body fat in areas that persist despite exercise and diet.
MORE
Jun
2002
Vol. 21. No. 2

The Less Common Skin Cancers

Henry W Randle, MD, PhD

The purpose of this chapter is to provide guidelines for managing the other skin cancers and to provide a heightened awareness of them.

MORE